Skip to content

Screening for prostate cancer: USPSTF recommendation

Published: October 18, 2026Updated: October 18, 2026

Moyer VA, Force USPST

Annals of Internal Medicine · 2014

This clinical guideline evaluates the intervention under study in relation to the primary clinical outcome. Evidence level: III.

Quick summary

循证研究:PSA筛查前列腺癌争议

Medically reviewed by WellAlly Editorial TeamLast reviewed October 18, 2026Editorial policy

Key facts at a glance

DOI
10.1093/jnci/djv298
PMID
26397558
Journal
Annals of Internal Medicine
Year
2014
Study type
guideline
Evidence level
III
Intervention
PSA 筛查
Primary outcome
前列腺癌死亡
Open access
false

Study Overview

This clinical guideline and examined the primary clinical outcome.

Key Findings

Results regarding the primary clinical outcome are presented.

Clinical Conclusions

See original publication for detailed findings. Evidence level: III.

Abstract

"This clinical guideline synthesizes evidence on PSA 筛查 and 前列腺癌死亡.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed October 18, 2026. · Read our editorial policy

More guideline studies

View all